Patents for C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649) |
---|
07/26/2011 | US7985552 Dye conjugates of nucleotides and other biological substances |
07/20/2011 | CN102127019A Geldanamycin derivative, preparation thereof and medicament application thereof |
07/14/2011 | WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof |
07/13/2011 | CN102120730A 19-S-methyl geldanamycin and 4,5-dihydrogen-19-S-methyl geldanamycin and preparation method thereof |
07/06/2011 | CN102115460A Geldanamycin derivative and preparation method and application thereof |
07/06/2011 | CN101421246B Structure of contact power semiconductor used on a cooling surface |
07/05/2011 | US7973061 Anaplastic lymphoma kinase modulators and methods of use |
07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
06/30/2011 | US20110160175 18,21-Didesoxymacbecin Derivatives for the Treatment of Cancer |
06/22/2011 | EP2336112A1 Work up process of a material flow containing laurinlactam for recovering all contained components by combining crystallisation with subsequent distillation |
06/16/2011 | US20110144477 Method for Acquiring Electromagnetic Signals and Contrast Product Therefor |
06/14/2011 | US7960372 Bivalent Smac mimetics and the uses thereof |
06/09/2011 | US20110137027 Method for preparing lactames, comprising a photonitrosation step, followed by a beckmann transposition step |
06/09/2011 | US20110136752 Novel antibiotics |
06/03/2011 | WO2011063615A1 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof |
05/31/2011 | CA2430692C Geldanamycin derivative and use of same to treat cancer |
05/31/2011 | CA2429629C Ligand and complex for catalytically bleaching a substrate |
05/26/2011 | US20110124855 Method for isolation of laurolactam from a laurolactam synthesis process stream |
05/25/2011 | CN102070528A Method for recovery of value materials present in stream containing laurolactam by means of integrated crystallization and downstream distillation |
05/19/2011 | US20110118459 High performance luminescent compounds |
05/17/2011 | US7943800 Migrastatin analogs and uses thereof |
05/04/2011 | CN102039179A Catalytic component for preparing amide and method for preparing amide |
04/28/2011 | WO2011050276A1 Methods of using macrocyclic inhibitors of serine protease enzymes |
04/27/2011 | CN102036966A Difluorinated tripeptides as HCV serine protease inhibitors |
04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
04/21/2011 | US20110091452 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies |
04/14/2011 | US20110086110 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
04/13/2011 | CN102015652A Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
03/31/2011 | WO2011037208A1 Novel compound and method for producing amide compound using same |
03/29/2011 | US7915306 Macrocyclic compounds useful as pharmaceuticals |
03/23/2011 | EP2297109A1 A process for isolation and purification of geldanamycin |
03/17/2011 | US20110065913 Process for producing laurolactam |
03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
03/15/2011 | US7906105 Zinc-activated contrast agents |
03/09/2011 | EP2292599A1 Process for producing laurolactam |
03/08/2011 | US7902354 Lapachone compounds and methods of use thereof |
03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
02/22/2011 | US7893255 Beckmann rearrangement in the gas phase at a temperature of between 180 and 450 degrees C with zeolite catalyst |
02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
02/10/2011 | US20110034687 Process for producing amide or lactam |
02/10/2011 | US20110034686 Process for Isolation and Purification of Geldanamycin |
02/02/2011 | EP2279750A1 Aniline derivative having anti-rna viral activity |
02/01/2011 | US7879834 Spiroindoline modulators of muscarinic receptors |
01/27/2011 | US20110021481 Novel Compounds and Methods for Their Production |
01/19/2011 | EP2275407A1 Process for production of amide or lactam |
01/05/2011 | EP2268619A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
12/23/2010 | US20100324283 Process for producing laurolactam |
12/23/2010 | US20100324257 Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof |
12/21/2010 | US7855192 A 2-azabicyclo(16.3.1)docosa-1(21),4,6,10,18-penntaen-9-ylcarbamate derivative; Heat shock protein 90 inhibitors; hyperproliferative disease, breast cancer, ovarian cancer, leukemia, colon cancer, lung cancer |
12/21/2010 | CA2448896C Allylmercaptocaptopril compounds and uses thereof |
12/09/2010 | US20100311694 Set of Geldanamycin Derivatives and Their Preparation Methods |
12/08/2010 | CN1995020B Radioactive iodine-17- allylamino-17-demethoxygeldanamycin and its preparation method |
11/24/2010 | EP2253621A1 A set of geldanamycin derivatives and their preparation methods |
11/18/2010 | US20100291299 Strontium and barium precursors for use in chemical vapor deposition, atomic layer deposition and rapid vapor deposition |
11/17/2010 | CN101885705A Preparation method of carbonyl di-lactame |
11/16/2010 | US7833997 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
11/11/2010 | US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof |
11/04/2010 | WO2010126552A1 Potent cell-binding agent drug conjugates |
11/04/2010 | US20100279997 Analgesic that binds filamin a |
11/04/2010 | US20100279995 Novel Ansamycin Derivatives |
11/03/2010 | EP2245015A1 Difluorinated tripeptides as hcv serine protease inhibitors |
11/02/2010 | USRE41911 Epothilone derivatives |
10/26/2010 | USRE41895 Epothilone derivatives |
10/26/2010 | USRE41893 Epothilone derivatives |
10/21/2010 | US20100267944 Process for producing laurolactam |
10/21/2010 | US20100267943 Intermediates and methods for the preparation of epothilones |
10/20/2010 | EP2241552A1 Production method and beckmann rearrangement catalyst for producing a cyclic lactam compound |
10/19/2010 | US7816346 Benzoquinone imine-containing ansamycins and its acylation or alkylation derivatives; cellular proliferation, hyperproliferation; increase the bioavailability and reduce the toxicity associated with the natural product |
10/05/2010 | US7807826 Purification of a crude lactam mixture by means of melt crystallization |
09/28/2010 | US7803936 Compounds and methods for labeling oligonucleotides |
09/28/2010 | US7803793 For example, 4-(4-Chloro-phenoxy)-N-(1-hydroxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-(R)-yl)-benzenesulfonamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes |
09/21/2010 | US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents |
09/16/2010 | US20100234338 Chelating agents of metal ions, their methods of preparation and their applications |
09/10/2010 | WO2010101229A1 Method for producing amide compound |
09/07/2010 | US7790394 Methods of analyzing a biological sample |
09/01/2010 | EP2223911A1 Method for production of laurolactam |
08/19/2010 | US20100210597 C21-Deoxy Ansamycin Derivatives as Antitumor Agents |
08/17/2010 | US7776849 used as heat shock protein 90 inhibitors, for the preventing and/or treating for cancer and chronic myelocytic leukemia; antitumor agent; angiogenesis inhibitors; anticarcinorgenic agents |
08/12/2010 | US20100204467 Lanthanide (iii) ion complexing compounds, luminescent lanthanide (iii) ion complexes and use thereof as fluorescent labels |
08/04/2010 | CN101792418A Geldanamycin biosynthetic analog 19-O-glycyl geldana |
08/03/2010 | US7767663 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
08/03/2010 | US7767662 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents |
07/22/2010 | US20100184971 Metal nanoparticles, an electrode using them and a process of preparing metal nanoparticles |
07/20/2010 | US7759331 Pyridine-containing macroheterococylic compounds as kinase inhibitors |
07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
07/06/2010 | US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders |
06/16/2010 | CN101735149A Macro-cyclic amide compound with antibacterial and anti-tumour activities, preparation method thereof and application thereof |
05/06/2010 | WO2010050781A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
05/06/2010 | US20100113460 Organic Compounds |
04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
04/20/2010 | US7700587 Haloperidol analogs |
04/13/2010 | US7696350 exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one; mood disorder, depression, dysthymic disorder, bipolar disorder, cyclothymic disorder; sleep disorders; psychological disorders |
04/06/2010 | US7691840 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
03/24/2010 | EP2164830A2 Process for the preparation of dibenzo [b,d]azepin-6-one derivative |
03/24/2010 | CN101679678A Oxime free anti-skinning combination |
03/24/2010 | CN101679278A Process for the preparation of dibenzo [b,d]azepin-6-one derivative |
03/18/2010 | US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies |
03/17/2010 | CN101674826A Compounds, screens, and methods of treatment |
03/16/2010 | US7678784 4-amino-23,26-dichloro-13-oxa-3,5,18,21-tetraazatricyclo[20.2.2.29,12]octacosa-1(24),4,9,11,15,22,25,27-octaene-6,8,20-trione 8-(O-ethyloxime); beta -amyloid production blocking agent; neurodegenerative diseases, cognition activator; Alzheimer's disease, Down syndrome |